Frontiers in endocrinology · 2026
Comprehensive opportunistic osteoporosis screening with AI: retrospective development and prospective validation of dual-site BMD prediction from a single radiograph.
СтатьяВалидационное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lin Hsuan-Yin, Chai Jyh-Wen, Tseng Qingzong, Lin Cheng-Wei, Pan Kuan-Jung, Liu Kai-Wei, Shih Ya-Chu
Аннотация
PURPOSE: To develop and validate an AI algorithm that enables dual-site (spine and hip) BMD assessment for opportunistic osteoporosis screening using a single kidney-ureter-bladder (KUB) radiograph.
MATERIALS AND METHODS: In this institutional review board approved prospective study, we developed the SHield pipeline for opportunistic osteoporosis screening. From an initial dataset of 15,175 KUB images, a final cohort of 4,436 patients (mean age 69.0 ± 12.2 years) was included for model development after exclusions for suboptimal quality or incomplete region of interests. The pipeline analyzes both the spine and hip regions on a single KUB to predict site-specific BMD values. Finally, it integrates these dual-site predictions to determine the lowest T-score, mimicking the standard clinical DXA reporting protocol which evaluates both the lumbar spine and proximal femur.
RESULTS: On the internal test set (628 patients), the hip and spine AI models demonstrated Pearson correlation coefficients of 0.887 and 0.921 and RMSEs of 0.057 and 0.062, respectively, compared to DXA-measured BMD, achieving AUCs of 0.894 and 0.956 for predicting T-scores ≤-2.5. In a subsequent prospective feasibility study (51 patients), we employed a conservative detection threshold of Tm-score ≤-2.8 to minimize false positives and unnecessary referrals. The final AI pipeline achieved a Pearson correlation of 0.959, an AUC of 0.969, 100% PPV, 100% specificity, and 83.8% NPV.
CONCLUSION: This paper presents the first AI pipeline that enables gold-standard-aligned, dual-site BMD estimation and opportunistic osteoporosis screening from a single KUB radiograph. Validated prospectively, its high accuracy and specificity confirm its potential to significantly increase early detection rates without overwhelming clinical workflows.
MATERIALS AND METHODS: In this institutional review board approved prospective study, we developed the SHield pipeline for opportunistic osteoporosis screening. From an initial dataset of 15,175 KUB images, a final cohort of 4,436 patients (mean age 69.0 ± 12.2 years) was included for model development after exclusions for suboptimal quality or incomplete region of interests. The pipeline analyzes both the spine and hip regions on a single KUB to predict site-specific BMD values. Finally, it integrates these dual-site predictions to determine the lowest T-score, mimicking the standard clinical DXA reporting protocol which evaluates both the lumbar spine and proximal femur.
RESULTS: On the internal test set (628 patients), the hip and spine AI models demonstrated Pearson correlation coefficients of 0.887 and 0.921 and RMSEs of 0.057 and 0.062, respectively, compared to DXA-measured BMD, achieving AUCs of 0.894 and 0.956 for predicting T-scores ≤-2.5. In a subsequent prospective feasibility study (51 patients), we employed a conservative detection threshold of Tm-score ≤-2.8 to minimize false positives and unnecessary referrals. The final AI pipeline achieved a Pearson correlation of 0.959, an AUC of 0.969, 100% PPV, 100% specificity, and 83.8% NPV.
CONCLUSION: This paper presents the first AI pipeline that enables gold-standard-aligned, dual-site BMD estimation and opportunistic osteoporosis screening from a single KUB radiograph. Validated prospectively, its high accuracy and specificity confirm its potential to significantly increase early detection rates without overwhelming clinical workflows.